Developing Country Vaccine Manufacturers Network (DCVMN), 26-27 April 2001, Bandung, Indonesia

Vaccine

Volumn 20, Issue 3-4, 2001, Pages 285-287

  Henriks, J ^a   Poeloengan, Thamrin ^b   Raw, Isaias ^c   Martinez, Luis Herrera ^d   El Abbadi, Mohamed ^d  

^a Bio Farma   (Indonesia)

^b INSTITUTO BUTANTAN   (Brazil)

^c CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^d VACSERA   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TYPHOID VACCINE; CHOLERA VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS HEPATITIS B HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; UNCLASSIFIED DRUG; VACCINE;

BIOTECHNOLOGY; CHINA; CONFERENCE PAPER; DEVELOPING COUNTRY; DRUG RESEARCH; FINANCIAL MANAGEMENT; HUMAN; INDIA; INDONESIA; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; QUALITY CONTROL; VACCINATION; VACCINE PRODUCTION;

DEVELOPING COUNTRIES; DRUG INDUSTRY; HUMANS; VACCINES; WORLD HEALTH ORGANIZATION;

EID: 0035851380     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00333-4     Document Type: Conference Paper

References (4)

1. Introducing GAVI and the global fund for children's vaccines: Guest editorial
2. A systematic method for evaluating the potential viability of local vaccine producers